Symposia: Myelodysplastic Syndromes – Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, MDS, clinical trials, adult, Clinical Practice (Health Services and Quality), Non-Biological therapies, Translational Research, Clinical Research, health outcomes research, Chronic Myeloid Malignancies, CMML, Diseases, Therapies, real-world evidence, registries, Biological Processes, Myeloid Malignancies, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, MDS, clinical trials, adult, Clinical Practice (Health Services and Quality), Non-Biological therapies, Translational Research, Clinical Research, health outcomes research, Chronic Myeloid Malignancies, CMML, Diseases, Therapies, real-world evidence, registries, Biological Processes, Myeloid Malignancies, Study Population, Human
Sunday, December 11, 2022: 4:30 PM-6:00 PM
R06-R09
(Ernest N. Morial Convention Center)
Moderators:
Wanxing Chai-Ho, MD, David Geffen School of Medicine at UCLA
and
Mrinal M. M. Patnaik, MD, Mayo Clinic
Disclosures:
Chai-Ho: Gilead: Research Funding; Abbvie: Research Funding; Agios: Research Funding; Equillium: Research Funding; Kadmon: Research Funding; Syndax: Research Funding; Shattuck Lab: Research Funding; SUN pharma: Research Funding; Syros: Research Funding; Servier: Honoraria. Patnaik: Kura Oncology, Stem Line Pharmaceuticals: Research Funding.
Updates in management of MDS/MPN overlap and lower risk MDS
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH